Healthcare · NIFTY 500

Onesource Specialty Pharma Limited

NSEONESOURCE BSE544292 ISININE013P01021 SeriesEQ Listed on NSE · BSE

₹1,620.00 +38.30 (+2.42%) Updated 12 Nov, 6:47 pm IST

Open chart Back to screener

Price, daily close-12.75% in a year

Today

Open: ₹1,583.10
Prev close: ₹1,581.70
Day high: ₹1,635.10
Day low: ₹1,577.10
Volume: 2.78 L
Value traded: ₹44.58 Cr
Upper circuit: ₹1,898.00
Lower circuit: ₹1,265.40
52W high: ₹1,917.80
52W low: ₹1,057.00
1 month: +8.23%
6 months: -11.29%

52W low52W high

Ratios

Key numbers

Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.

Market cap₹18,572 Cr

P/E (TTM)—

P/B3.14

Book value / share₹516.48

EPS (TTM)₹-4.25

ROE-1.2%

Dividend yield—

Dividend (12m)—

Net margin (TTM)-4.8%

Operating margin26.5%

Debt / equity0.25

Current ratio1.02

EV / EBITDA61.15

Sales growth (YoY qtr)+37.20%

Profit growth (YoY qtr)+100.00%

Sales CAGR 3Y—

Profit CAGR 3Y—

Shares11.46 Cr

Quarterly results

Results for each quarter

Last 8 quarters, consolidated, ₹ crore. Hover a bar to see the number.

Revenue and net profit

68.00.0

Sep 24

3930.0

Dec 24

42698.2

Mar 25

327-0.2

Jun 25

37610.5

Sep 25

290-88.7

Dec 25

4284.6

Mar 26

4490.0

Jun 26

Revenue · QoQ (vs last quarter)

—+477%+8.5%-23%+15%-23%+47%+4.9%

Revenue · YoY (vs a year ago)

————+453%-26%+0.5%+37%

Net profit · QoQ (vs last quarter)

———-100%+5,737%-946%+105%-100%

Net profit · YoY (vs a year ago)

——————-95%+100%

RevenueNet profitLine = trend

-18.82

Sep 24

-6.31

Dec 24

8.59

Mar 25

-0.02

Jun 25

0.91

Sep 25

-7.74

Dec 25

0.40

Mar 26

2.18

Jun 26

EPS (₹) · YoY (vs a year ago)

————+105%-23%-95%+11,000%

EPS (₹)Line = trend

₹ Cr	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25	Dec 25	Mar 26	Jun 26
Revenue	68.0	393	426	327	376	290	428	449
Other income	0.6	5.4	2.9	5.3	3.0	4.6	2.1	3.8
Total income	68.6	398	429	333	379	295	430	453
Raw material	12.3	92.9	91.0	83.4	124	87.7	145	141
Purchases	0.0	0.0	-8.0	0.0	0.0	0.0	0.0	0.0
Employee cost	22.8	57.3	51.1	58.4	62.8	64.2	62.7	68.7
Other expenses	32.8	90.5	81.5	87.4	93.0	114	127	115
Total expenses	108	364	345	334	373	381	431	428
Operating profit	0.1	42.7	183	85.6	106	10.2	92.0	119
OPM %	0.2%	10.9%	42.8%	26.2%	28.3%	3.5%	21.5%	26.5%
Finance cost	20.7	45.8	33.4	27.5	34.0	38.2	22.5	30.8
Depreciation	19.1	68.8	68.5	67.8	69.8	69.6	71.8	71.7
Exceptional items	—	-101	—	-2.9	—	-7.1	0.0	-4.3
Profit before tax	-39.1	-66.5	83.5	-4.4	5.7	-93.0	-0.3	20.3
Tax	0.0	2.3	-15.4	-4.2	-4.7	-4.3	-4.9	-4.7
Net profit	-39.3	-68.8	98.2	-0.2	10.5	-88.7	4.6	25.0
Profit to shareholders	0.0	0.0	—	—	—	-88.7	4.6	0.0
EPS (₹)	-18.82	-6.31	8.59	-0.02	0.91	-7.74	0.40	2.18

Profit & loss

Results for each year

2 financial years (April to March), consolidated, ₹ crore.

Sales, operating profit and net profit

1,445356-18.0

FY25

1,422294-73.8

FY26

Revenue · YoY (vs a year ago)

—-1.6%

Net profit · YoY (vs a year ago)

—-311%

RevenueOperating profitNet profitLine = trend

₹ Cr	FY25	FY26
Revenue	1,445	1,422
Other income	17.5	15.0
Total expenses	1,419	1,519
Employee cost	215	242
Operating profit	356	294
OPM %	24.6%	20.7%
Finance cost	166	122
Depreciation	274	279
Profit before tax	-67.1	-92.0
Tax	-49.8	-18.2
Net profit	-18.0	-73.8
Profit to shareholders	—	-73.8
Net margin %	-1.2%	-5.2%
EPS (₹)	-1.63	-6.44

Balance sheet

Assets and debt

At each year end (and the latest half year), ₹ crore.

Equity, debt and assets

5,881772156

Mar 25

5,8311,27635.7

Mar 26

5,9211,48414.2

Sep 26

Shareholders' equity · YoY (vs a year ago)

—-0.8%—

Shareholders' equityBorrowingsCashLine = trend

₹ Cr	Mar 25	Mar 26	Sep 26
Shareholders' equity	5,881	5,831	5,921
Long-term borrowings	219	564	584
Short-term borrowings	552	713	899
Total borrowings	772	1,276	1,484
Current liabilities	1,114	1,442	1,664
Fixed assets (PPE)	897	926	1,188
Inventories	158	439	446
Trade receivables	417	690	1,033
Cash & equivalents	156	35.7	14.2
Current assets	1,086	1,426	1,697
Total assets	7,550	8,210	8,586
Debt / equity	0.13	0.22	0.25

Cash flow

Cash coming in and going out

For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.

Operating, investing and financing cash

-21.5-2011,987

FY25

8.5-495359

FY26

Operations · YoY (vs a year ago)

—+140%

OperationsInvestingFinancingLine = trend

₹ Cr	FY25	FY26
Cash from operations	-21.5	8.5
Cash from investing	-201	-495
Cash from financing	1,987	359
Spent on fixed assets	0.0	-569
Free cash flow	-21.5	-561
Net cash flow	1,765	-127

Shareholding

Who holds the shares

Promoter and public holding at each quarter end, as filed with NSE.

Holding over time

37.8%Dec 24

34.3%Mar 25

29.8%Jun 25

29.8%Sep 25

29.9%Dec 25

30.5%Mar 26

30.5%Jun 26

30.5%Sep 26

Promoter & groupPublic

Latest (30 Sep 2026)

30.5%promoter

Promoter & group: 30.47%
Public (FIIs, mutual funds, retail…): 69.53%
Promoter change, last quarter: -0.01 pts

Dividends & news

Latest dividends and announcements

Dividends & corporate actions

No recent corporate actions.

Board meetings

OneSource Specialty Pharma Limited has informed the Exchange about Board Meeting to be held on 27-Oct-2026 to inter-alia consider and approve the Una…27-Oct-2026
the financial results for the period ended September 30, 202627-Oct-2026
ONESOURCE SPECIALTY PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 24-Jul-2026 to inter-alia consider and approve the Una…24-Jul-2026
the unaudited financial results for the period ended Jun 30, 202624-Jul-2026
ONESOURCE SPECIALTY PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 24-Jul-2026 to inter-alia consider and approve the Una…24-Jul-2026

Filings with NSE

General Updates5 Nov
Analysts/Institutional Investor Meet/Con. Call Updates3 Nov
Press Release30 Oct
Copy of Newspaper Publication28 Oct
Analysts/Institutional Investor Meet/Con. Call Updates27 Oct
Press Release27 Oct
Updates27 Oct

Latest news

OneSource Specialty Pharma Share Price Jumps Over 7%HDFC Sky · 27 Oct, 12:30 pm OneSource Specialty Pharma (NSEI:ONESOURCE) - Stock AnalysisSimply Wall St · 27 Oct, 12:30 pm Onesource Specialty Pharma Ltd. Peer Comparison – Compare with OthersValue Research · 30 Aug, 7:55 pm Onesource Specialty Pharma up 5% in weak market; rallies 21% in one weekBusiness Standard · 24 Apr, 12:30 pm Buy Onesource Specialty Pharma; target of Rs 2400: ICICI SecuritiesMoneycontrol.com · 27 Jul, 12:30 pm OneSource Specialty Pharma Q1FY27 revenue up 37%, EBITDA surges 39%scanx.trade · 21 Jul, 12:34 pm OneSource Specialty Pharma shares fall as Q4 profit plunges 95%, margin halvesCNBC TV18 · 13 May, 12:30 pm Onesource Specialty Pharma Ltd | Stock Share Price LiveMarketSmith India · 18 Apr, 5:50 am

About

About Onesource Specialty Pharma Limited

Onesource Specialty Pharma Limited is listed on the NSE under the symbol ONESOURCE and belongs to the Healthcare sector.

Company details

Company name: Onesource Specialty Pharma Limited
NSE symbol: ONESOURCE
BSE scrip code: 544292
ISIN: INE013P01021
Listed on: NSE, BSE
Series: EQ (normal equity)
Listed on NSE since: 24 Jan 2025
Face value: ₹1 per share
Market lot: 1 share
Shares issued: 11.46 crore
Index: NIFTY 500
Sector (NSE): Healthcare
Industry: Pharmaceuticals: Major
Managing director / CEO: Neeraj Sharma
Chair: Arun Kumar Pillai
Headquarters: Navi Mumbai, IN
Registered address: Star 1, Opp IIM Bengaluru Bilekahalli, Bannerghatta Road, Bengaluru South, Karnataka, India-560076
Founded: 2007
Employees: 2,289
Financial year: April to March
Results basis: Consolidated
Website: onesourcecdmo.com

Peers

Other Healthcare stocks

Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.

India, Wall Street, crypto and commodities, live.

Every product, one clear workflow.

Built from data, on the record.

A clearer view of the markets.

Calculators and tools that show the maths.

Read the numbers, not the noise.

Onesource Specialty Pharma Limited

Today

Ratios

Quarterly results

Revenue and net profit

Profit & loss

Sales, operating profit and net profit

Balance sheet

Equity, debt and assets

Cash flow

Operating, investing and financing cash

Shareholding

Holding over time

Latest (30 Sep 2026)

Dividends & news

Dividends & corporate actions

Board meetings

Filings with NSE

Latest news

About

Company details

Peers